Evaluating the feasibility, preliminary efficacy, and safety of psilocybin- assisted psychotherapy for treatment- resistant obsessive- compulsive disorder: an open- label clinical trial.
Evaluating the feasibility, preliminary efficacy, and safety of psilocybin- assisted psychotherapy for treatment- resistant obsessive- compulsive disorder: an open- label clinical trial.
评估裸盖菇素辅助心理治疗治疗难治性强迫症的可行性、初步疗效和安全性：一项开放标签临床试验。
批准号：
486642
负责人：
Baer Jenna
金额：
$1.27万
依托单位：
依托单位国家：
加拿大
项目类别：
Studentship Programs
财政年份：
2022
资助国家：
加拿大
项目状态：
已结题
起止时间：
2022-12-01 至 2023-12-01
中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The following proposed research is an open label clinical trial assessing the safety and clinical effects of the administration of psilocybin, a psychedelic commonly known as ‘magic mushrooms’, along with psilocybin assisted psychotherapy (PAP) in those w
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金
